November 26, 2018: Cobra and Pall to make commercialisation of gene therapies safer, faster, and cheaper than ever before, help increase patient access to gene therapy and further establish best practices in manufacturing
January 29, 2018: New name reinforces Pall's commitment to providing standard configurable single-use, stainless steel and hybrid technologies for fed-batch and continuous processes across upstream, downstream and formulation and filling applications in biotech
April 15, 2018: Patrnership to bring together Artesyn Biosolutions' valves and fluid handling technologies with Pall's Allegro solutions including bioreactors, range of downstream automated equipment and mixers to enable customers to implement efficient single-use manufacturing lines
November 14, 2017: New modules enable fully continuous processes in UF/DF processing steps, available in a range of size formats for use in one or more locations of a continuous mAb downstream purification process
October 5, 2016: New collaboration to deliver complete solutions for industrial-scale bioreactor expansion of human Mesenchymal Stem/Stromal Cells (hMSCs), to accelerate product development, reduce clinical translation timelines and streamline the commercialization pathway for stem cell-based therapies
September 24, 2018: New collaboration to see G-CON PODs customized with Pall technologies, addressing customer demand for higher efficiencies, while enjoying more flexibility through scale-out and localization of manufacturing
July 23, 2018: New partnership to integrate novel biologics and biosimilars process know-how and regulatory experience from molecule selection to full commercialization, with efficient upstream and downstream process equipment and facility design solutions for manufacturers
July 17, 2018: Agreement will meet increased demand for more targeted and personalized medicines currently driving growth and development in the mAb manufacturing market and offer a complete solution to customers
September 3, 2018: Celltheon and Pall to provide an integrated, cost-effective, time efficient end-to-end solution for research and bioproduction to expedite drug development and provide solutions for unmet needs in bioprocessing
November 9, 2017: New training courses starting early 2018 focused on continuous bioprocessing advances will detail the state of the industry, and the advantages and practical implications of transitioning from batch to semi- or fully-continuous bioprocess methodologies
June 15, 2015: Announcing Pall's signing of an exclusive license for acoustic wave separation (AWS), a disruptive technology from FloDesign Sonics (FDS) for cell culture clarification for both fed-batch and perfusion applications
April 26, 2016: This new product will eliminate reliance on centrifugation for cell culture clarification, reducing buffer requirements by around 75%, and create a continuous feed stream for direct integration with Pall's full portfolio
Pall Corporation is an industry leader and manufacturer of proprietary filtration, separation and purification products and solutions. Pall offers a wide range of filters to meet your fluid management needs.
Pall Aerospace has the expertise in protecting every critical piece of fluid equipment on an aircraft and experience with virtually every aerospace and defense program that requires fluid filtration and separation.
Chemicals and polymers require a significant amount of filtration, separation, and purification during the manufacturing process. Discover why we are the trusted industry leader when it comes to filtration solutions for chemicals and polymers.